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A33-year-old nonsmoker had an 8-month history ofhemoptysis. He was otherwise well, with normalhematologic and biochemical indices, and his med-ical history was unremarkable. Fiberoptic bron-
choscopy elsewhere showed external compression of the air-
way, consistent with a mediastinal mass, but no endobronchial
lesions. Biopsy specimens showed capillary proliferation in the
subepithelial stroma but no cytologic features of malignancy.
The possibility of a benign or low-grade vascular neoplasm was
raised. After the biopsy, the patient had a massive hemoptysis
necessitating blood transfusion. Subsequent contrast computed
tomographic and magnetic resonance imaging scans demon-
strated an extensive mediastinal mass of high vascularity, which
extended from above the level of the azygos arch to the left
atrium inferiorly. The tumor also encased the carina, esophagus,
and several major blood vessels within the mediastinum (Figure
1, A and B). On examination with a rigid bronchoscope, there
was profuse arterial bleeding at the biopsy site from the left
main bronchus and evidence of further recent bleeding distally.
Hemostasis was secured by cauterizing the arterial bleeding
point with a diathermy loop. Because of uncertainty over the
histologic diagnosis and degree of malignancy, cervical medi-
astinoscopy was also undertaken, which showed paratracheal
and subcarinal tissues infiltrated by a vascular mass containing
several large tortuous arteries. Biopsy showed similar features
to the bronchial biopsy, with lobules of cytologically benign
capillaries infiltrating mediastinal soft tissues. A vascular phe-
notype was confirmed by positive immunohistochemical stain-
ing for CD34 and factor 8, and a diagnosis of capillary hem-
angioma was made (Figure 2, A).
Surgical resection was considered inappropriate because of
diffuse mediastinal infiltration precluding complete resection,
and he was treated with recombinant alpha-2a interferon (3
megaunits given subcutaneously 3 times per week) for 6
months. This led to significant symptomatic benefit, and a
second computed tomographic scan demonstrated marked re-
duction in tumor bulk with only a small residual mass in the
subcarinal area. A complete resection was now considered
feasible. Another bronchoscopic examination showed normal
bronchial mucosa. A right posterolateral thoracotomy was used
for access. At thoracotomy, a 4-cm diameter, markedly fibrotic,
residual mass still containing tortuous arteries up to 5 mm in
diameter was seen. The mass extended from the right side of the
trachea to the subcarinal region. The tumor was resected by
sharp dissection, with care taken to ligate individual vessels
before dividing them. Surgically, a complete resection was
possible, and microscopically, the mass consisted of an abun-
dance of thick-walled blood vessels with the vessels lying
within dense fibrous stroma (Figure 2, B). The cellular capillary
proliferation was no longer present. The patient remains symp-
tom-free and disease-free 18 months after resection.
Discussion
Tumors of vascular origin usually appear in childhood. Common
locations include subcutaneous tissue, liver, bone, central nervous
system, and spleen. Isolated mediastinal localization is rare and
accounts for fewer than 2% of all mediastinal tumors.1,2 Vascular
tumors comprise a wide spectrum of histopathologic entities rang-
ing from benign hemangiomas, through low-grade malignant tu-
mors such as capillary hemangiomas, up to overtly malignant
angiosarcomas.3
Symptoms in patients with mediastinal hemangioma are
related to compression or invasion of adjacent structures and
may include symptoms of airway obstruction or dysphagia.
Other rare presentations include superior vena cava obstruction,
vocal cord paralysis, spontaneous hemothorax, or significant
hemoptysis that may even require blood transfusion, as de-
scribed in this case.4 Complete surgical resection remains the
optimal treatment.3,4 but resection is considered extremely haz-
ardous in patients with extensive involvement of mediastinal
structures. Nevertheless, even incomplete resection has been
advocated by some authors.2
Alpha-2a interferon is a highly purified recombinant DNA
product and is a potent angiogenesis inhibitor that acts by
blocking the action of basic fibroblast growth factor. In the
proliferative phase, hemangiomas are characterized by endothe-
lial cell migration and proliferation, and basic fibroblast growth
factor is a major stimulus for this proliferation. It is therefore
believed that alpha-2a interferon inhibits endothelial cell pro-
liferation by blocking the actions of basic fibroblast growth
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factor,5 and there is considerable experience with its use in
children with hemangiomas at different sites including life-
threatening airway hemangioma.6
However, very little experience with alpha-2a interferon has
been reported in adults, especially relating to mediastinal heman-
giomas, and this case documents both a significant clinical re-
sponse in this age group and a reduction of tumor bulk to a degree that
enabled complete resection of a tumor initially considered inoperable.
However, although alpha-2a interferon led to marked symptomatic
benefit without any side effects in this case, neurologic, cardiac, and
visual side effects are frequently reported in children.6
It is also interesting to note the change in tumor morphology
after chemotherapy, with an absence of the capillary proliferation
seen on the initial bronchoscopic and mediastinal biopsies and
replacement by dense fibrosis, while the larger feeding vessels
remained. This suggests that inhibition of basic fibroblast growth
factor leads to preferential regression or inhibition of the endothe-
lial cells in the areas of capillary proliferation.
In conclusion, use of alpha-2a interferon may represent a sig-
nificant step forward in the management of such vascular tumors,
especially in situations in which the tumor is initially considered to
be inoperable.
Figure 2. A, A mediastinal biopsy shows lobules of proliferating capillaries (arrows) infiltrating soft tissues,
features characteristic of a hemangioma (hematoxylin and eosin stain; original magnification 40). B, A section
from the postchemotherapy resection specimen shows abundant tortuous feeder vessels only, lying within fibrous
stroma. The vessels show prominent intimal fibrosis (elastic van Gieson stain; original magnification 20).
Figure 1. A and B, Computed tomographic scans of the chest showing extensive soft tissue mass encasing the
trachea at the bifurcation and extending to the subcarinal area abutting the adjacent structures. Note the large
blood vessels present within the soft tissue mass.
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